Work

Targeting NFE2L2/KEAP1 mutations in advanced NSCLC with the TORC1/2 inhibitor TAK-228.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.9085

Authors: Paul K. Paik, Linda Su Hyun Ahn, Michelle S. Ginsberg, Andrew J. Plodkowski, Rachel Kim, L. Austin Doyle, Charles M. Rudin

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2957635541

Cites:

Cited by: 7

Related to: 10